SNX7
Modify Date: 2024-04-06 11:57:21
SNX7 structure
|
Common Name | SNX7 | ||
|---|---|---|---|---|
| CAS Number | 685097-43-2 | Molecular Weight | 238.28 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 416.4±48.0 °C at 760 mmHg | |
| Molecular Formula | C15H14N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 205.7±29.6 °C | |
Use of SNX7SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1]. |
| Name | WAY-323879 |
|---|---|
| Synonym | More Synonyms |
| Description | SNX7 is a Cyclin-Dependent Kinase Inhibitor (CDKI) pathway inhibitor. SNX7 can be used for research of senescence-related and other CDKI-related diseases[1]. |
|---|---|
| Related Catalog | |
| References |
[1]. Bey-Dih Chang, et al. Cdki pathway inhibitors and uses thereof. Patent. US20090281129. |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 416.4±48.0 °C at 760 mmHg |
| Molecular Formula | C15H14N2O |
| Molecular Weight | 238.28 |
| Flash Point | 205.7±29.6 °C |
| Exact Mass | 238.110611 |
| LogP | 4.58 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.605 |
| 1H-Benzimidazole, 1-ethyl-2-[(E)-2-(2-furanyl)ethenyl]- |
| 1-Ethyl-2-[(E)-2-(2-furyl)vinyl]-1H-benzimidazole |